Kybella is a non-surgical injectable treatment designed to reduce submental fat, commonly known as a double chin. It is the first and only FDA-approved injectable specifically for this indication. The active component, synthetic deoxycholic acid, is a substance that the body naturally produces to facilitate fat breakdown. Kybella functions by permanently destroying fat cells, which are subsequently eliminated by the body, resulting in a more refined chin profile. This treatment offers long-term results for addressing the appearance of a double chin.

​

The primary concern expressed by clients who have reached their optimal weight is the presence of a "double chin," characterized by persistent fatty tissue in the submental area. This condition is often attributed to genetic factors rather than excess weight. A thorough assessment by your healthcare provider will determine whether Kybella treatment is suitable for addressing your submental fat concerns. If you are identified as a candidate for this treatment, your qualified provider will develop a comprehensive treatment plan, detailing the number of injection sessions required and providing an estimated cost for the entire course of treatment.

​

Cost of Kybella Treatment:

Treatment ranges from 1250-6000, based on individualized assessments  and recommendations.

Down time:

Most patients return to normal activates post treatment after 48 hours. Swelling and mild to moderate pain are usually the most reported symptoms by patients.